Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE
I turned 38 last March and had been dealing with stubborn weight for close to a decade
Adjunctive therapies such as bimagrumab and myostatin inhibitors are currently under investigation
The MHRA has not approved any GLP-1 receptor agonist for use below the labelled doses, and this approach falls outside current prescribing guidelines
For Wegovy, the escalation occurs over 16-20 weeks to reach the 2.4 mg maintenance dose
Factors such as age, overall health, and other medications being taken can influence whether a person experiences a fast heart rate